Obdulia Rabal

3.4k total citations
59 papers, 1.8k citations indexed

About

Obdulia Rabal is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Obdulia Rabal has authored 59 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 14 papers in Computational Theory and Mathematics and 11 papers in Pharmacology. Recurrent topics in Obdulia Rabal's work include Computational Drug Discovery Methods (14 papers), Histone Deacetylase Inhibitors Research (12 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). Obdulia Rabal is often cited by papers focused on Computational Drug Discovery Methods (14 papers), Histone Deacetylase Inhibitors Research (12 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). Obdulia Rabal collaborates with scholars based in Spain, China and United States. Obdulia Rabal's co-authors include Julen Oyarzábal, Martin Krallinger, Alfonso Valencia, Anália Lourenço, Jordi Teixidó, José I. Borrell, Miguél Vázquez, Juan A. Sánchez‐Arias, Mar Cuadrado‐Tejedor and Ana Ugarte and has published in prestigious journals such as Chemical Reviews, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Obdulia Rabal

59 papers receiving 1.7k citations

Peers

Obdulia Rabal
Vlado Dančík United States
Ðắc-Trung Nguyễn United States
David Méndez Colombia
Florian Nigsch Switzerland
Obdulia Rabal
Citations per year, relative to Obdulia Rabal Obdulia Rabal (= 1×) peers Niklas Blomberg

Countries citing papers authored by Obdulia Rabal

Since Specialization
Citations

This map shows the geographic impact of Obdulia Rabal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Obdulia Rabal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Obdulia Rabal more than expected).

Fields of papers citing papers by Obdulia Rabal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Obdulia Rabal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Obdulia Rabal. The network helps show where Obdulia Rabal may publish in the future.

Co-authorship network of co-authors of Obdulia Rabal

This figure shows the co-authorship network connecting the top 25 collaborators of Obdulia Rabal. A scholar is included among the top collaborators of Obdulia Rabal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Obdulia Rabal. Obdulia Rabal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Christophe, et al.. (2021). Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases. Methods in molecular biology. 2390. 383–407. 20 indexed citations
2.
López‐López, Edgar, Obdulia Rabal, Julen Oyarzábal, & José L. Medina‐Franco. (2020). Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach. Journal of Computer-Aided Molecular Design. 34(6). 659–669. 18 indexed citations
3.
Cuadrado‐Tejedor, Mar, Marta Pérez-González, Cristina García‐Muñoz, et al.. (2019). Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease. Frontiers in Aging Neuroscience. 11. 149–149. 33 indexed citations
4.
Miguel, Irene de, Josune Orbe, Juan A. Sánchez‐Arias, et al.. (2018). Phenotypic Screening To Discover Novel Chemical Series as Efficient Antihemorrhagic Agents. ACS Medicinal Chemistry Letters. 9(5). 428–433. 2 indexed citations
5.
Lozano, Teresa, Marta Pérez-González, Marta Gorraiz, et al.. (2018). Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice. Frontiers in Immunology. 9. 68–68. 14 indexed citations
6.
Rabal, Obdulia, Juan A. Sánchez‐Arias, Mar Cuadrado‐Tejedor, et al.. (2018). Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 150. 506–524. 58 indexed citations
7.
Roncal, Carmen, Obdulia Rabal, Estefanía Toledo, et al.. (2018). MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes. Translational Stroke Research. 10(4). 389–401. 22 indexed citations
8.
Capella-Gutiérrez, Salvador, et al.. (2017). LimTox: a web tool for applied text mining of adverse event and toxicity associations of compounds, drugs and genes. Nucleic Acids Research. 45(W1). W484–W489. 31 indexed citations
9.
Soldevilla, Mario Martínez, Helena Villanueva, Teresa Lozano, et al.. (2017). Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA). PLoS ONE. 12(9). e0185169–e0185169. 36 indexed citations
10.
Rodríguez-Madoz, Juan R., Edurne San José‐Eneriz, Obdulia Rabal, et al.. (2017). Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome. PLoS ONE. 12(12). e0190275–e0190275. 11 indexed citations
11.
Guruceaga, Elizabeth, Ibai Tamayo, José Ramón González‐Porras, et al.. (2016). Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk. Cardiovascular Research. 110(3). 309–318. 30 indexed citations
12.
Pérez‐Pérez, Martín, Gael Pérez‐Rodríguez, Obdulia Rabal, et al.. (2016). The Markyt visualisation, prediction and benchmark platform for chemical and gene entity recognition at BioCreative/CHEMDNER challenge. Database. 2016. baw120–baw120. 9 indexed citations
13.
Cuadrado‐Tejedor, Mar, Carolina García, Juan A. Sánchez‐Arias, et al.. (2016). A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice. Neuropsychopharmacology. 42(2). 524–539. 86 indexed citations
14.
Martínez‐Pinilla, Eva, Obdulia Rabal, Irene Reyes‐Resina, et al.. (2016). Two Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay. Journal of Pharmacology and Experimental Therapeutics. 358(3). 580–587. 20 indexed citations
15.
Rabal, Obdulia, Fernando Pastor, Helena Villanueva, et al.. (2016). In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding. Molecular Therapy — Nucleic Acids. 5(10). e376–e376. 39 indexed citations
16.
17.
Albarrán, María I., Rosa M. Álvarez, Obdulia Rabal, et al.. (2012). Fragment-Hopping-Based Discovery of a Novel Chemical Series of Proto-Oncogene PIM-1 Kinase Inhibitors. PLoS ONE. 7(10). e45964–e45964. 19 indexed citations
18.
Rabal, Obdulia, et al.. (2010). An integrated one-step system to extract, analyze and annotate all relevant information from image-based cell screening of chemical libraries. Molecular BioSystems. 6(4). 711–720. 11 indexed citations
19.
Link, Wolfgang, Julen Oyarzábal, María I. Albarrán, et al.. (2009). Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases. Journal of Biological Chemistry. 284(41). 28392–28400. 69 indexed citations
20.
Pettersson, Sofia, Violeta I. Pérez‐Nueno, Raimon Puig de la Bellacasa, et al.. (2008). Discovery of Novel Non‐Cyclam Polynitrogenated CXCR4 Coreceptor Inhibitors. ChemMedChem. 3(10). 1549–1557. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026